Skip to content

Welcome to Discover Pharma! Today is : October 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

RSV

  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    ENA Respiratory begins Phase 2a dosing of nasal antiviral INNA-051

    ENA Respiratory has begun dosing participants in Part B of [...]

    September 15, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development

    Sanofi to acquire Vicebio for $1.6 billion, boosting next-generation multivalent respiratory vaccines

    Sanofi has agreed to acquire Vicebio Ltd, a biotechnology company [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • NICE recommends maralixibat for Alagille syndrome itching
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Mursla Bio validates liver-specific liquid biopsy platform
    Categories: Clinical & Regulatory, Genomics and sequencing, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • E2 secures FDA clearance for pulmonary embolism thrombectomy system
    Categories: Clinical & Regulatory, Medical devices
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top